After winning a $500,000 verdict against a Johnson & Johnson unit last week when a Philadelphia jury found the antipsychotic drug Risperdal had hidden risks and caused a male patient to grow breasts, the Wisconsin man on Friday asked a judge for a new trial on damages.
Timothy Stange, who secured a favorable jury verdict on Dec. 11 in his case against Janssen Pharmaceuticals Inc., said in a post-trial motion that as a result of judicial error in pretrial orders and the judge’s refusal to give requested jury instructions, he was unfairly prevented from pursuing a claim for punitive damages at trial and unable to ask the jury for additional damages stemming from bullying he suffered as a result of growing female breasts.
J&J is represented by Michael Kelly of McCarter & English LLP.